OverviewChartNewsTraderScreen

Morgan Stanley Knock-Out PGR/  DE000MA5QB87  /

EUWAX
5/21/2024  9:03:56 PM Chg.+0.20 Bid10:00:32 PM Ask10:00:32 PM Underlying Strike price Expiration date Option type
9.98EUR +2.04% -
Bid Size: -		 -
Ask Size: -		 Progressive Corporat... 101.2747 - 12/31/2078 Call
GlobeNewswire 5/21 Team, Inc. Showcases Strategic Vision With New Investor Presentation and Recording
GlobeNewswire 5/21 Aerovate Therapeutics Presents Baseline Data from the Phase 2b Portion of the IMPAHCT Trial at the A...
GlobeNewswire 5/21 Second Snoqualmie Casino Guest Hits $1M Jackpot on Light & Wonder’s 5 TREASURES EXPLOSION™ Slot Mach...
GlobeNewswire 5/21 Inventiva reports 2024 First Quarter Financial Information¹ and provides a corporate update
GlobeNewswire 5/21 Sana Biotechnology Highlights Publication in Nature Biotechnology of Novel In Vivo Preclinical Data ...
GlobeNewswire 5/20 Avalyn Presents Clinical Data on AP01 for Pulmonary Fibrosis, Including Long-Term Efficacy and Imagi...
TeleTrader 5/20 Yellen says US against tax on billionaires
GlobeNewswire 5/20 APRINOIA Therapeutics Announces Fast Track Designation Granted by U.S. FDA to APN-1607 (florzolotau)...
GlobeNewswire 5/20 Dyne Therapeutics Announces New Clinical Data from ACHIEVE Trial of DYNE-101 in DM1 and DELIVER Tria...
GlobeNewswire 5/20 MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Preventio...
GlobeNewswire 5/16 BMW unveils The BMW XM Mystique Allure, a one-of-a-kind luxury vehicle inspired by the iconic superm...
GlobeNewswire 5/15 Eyenovia Reports First Quarter 2024 Financial Results and Provides Updates on its Myopia Phase III P...
TeleTrader 5/15 Slovakian opposition denies connection to Fico's attack
GlobeNewswire 5/15 Progressive Reports April 2024 Results
GlobeNewswire 5/14 MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Treatment...
GlobeNewswire 5/13 Avalyn Announces Multiple Presentations on its Lead Program, AP01, for Pulmonary Fibrosis and its Ap...
GlobeNewswire 5/13 BridgeBio Pharma Presents Additional Data and Analyses from its Phase 3 ATTRibute-CM Study in Transt...
GlobeNewswire 5/13 Fulcrum Therapeutics Enters into a Collaboration and License Agreement with Sanofi for the Developme...
GlobeNewswire 5/9 Travere Therapeutics to Present at National Kidney Foundation Spring Clinical Meetings and the 61st ...
GlobeNewswire 5/9 Freeline Presents Positive New Data from Phase 1/2 Trial of FLT201, Its Novel Gene Therapy Candidate...
GlobeNewswire 5/8 Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Plan...
GlobeNewswire 5/7 MediciNova Receives Issue Notification for New Patent Covering Extended-Release Formulations of MN-1...
GlobeNewswire 5/6 Belite Bio Presents Additional Analysis from Phase 2 Study of Tinlarebant in Stargardt Disease at th...
GlobeNewswire 5/4 The National Fire Sprinkler Association's Class of 2024: Honoring Fire Sprinkler Industry Greats
GlobeNewswire 5/2 PyroGenesis Announces 28-Day Lab Strength Tests Achieve Up to 99.56% Above Compressive Strength Targ...